BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 418435)

  • 1. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.
    Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1978 Apr; 56(3):279-85. PubMed ID: 418435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
    Taylor DA; Fennessy MR
    Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of (-)-trans-delta 9-tetrahydrocannabinol on regional brain levels and subcellular distribution of monoamines in the rat.
    Taylor DA; Fennessy MR
    Clin Exp Pharmacol Physiol; 1979; 6(5):541-8. PubMed ID: 498594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.
    Wu X; French ED
    Neuropharmacology; 2000 Jan; 39(3):391-8. PubMed ID: 10698005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to the effects of delta9-THC on shuttle-box performance and body temperature.
    ten Ham M
    Pharmacol Biochem Behav; 1977 Feb; 6(2):183-5. PubMed ID: 859896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of (-)-delta9-tetrahydrocannabinol on reserpine-induced hypothermia in rats.
    Englert LF; Ho BT; Taylor D
    Br J Pharmacol; 1973 Oct; 49(2):243-52. PubMed ID: 4793331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
    Finn DP; Beckett SR; Roe CH; Madjd A; Fone KC; Kendall DA; Marsden CA; Chapman V
    Eur J Neurosci; 2004 Feb; 19(3):678-86. PubMed ID: 14984418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats.
    Pryor GT; Larsen FF; Husain S; Braude MC
    Pharmacol Biochem Behav; 1978 Mar; 8(3):295-318. PubMed ID: 652837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.
    Bloom AS; Dewey WL
    Psychopharmacology (Berl); 1978 May; 57(3):243-8. PubMed ID: 97703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
    Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
    Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta9 -tetrahydrocannabinol increases brain temperature and inverts circadian rhythms.
    Perron RR; Tyson RL; Sutherland GR
    Neuroreport; 2001 Dec; 12(17):3791-4. PubMed ID: 11726796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1980; 68(3):261-7. PubMed ID: 6248916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs: effects on uptake of biogenic amines and on behavior.
    Hershkowitz M; Szechtman H
    Eur J Pharmacol; 1979 Nov; 59(3-4):267-76. PubMed ID: 230975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal administration of delta-9-tetrahydrocannabinol (THC) alters the neurochemical response to stress in the adult Fischer-344 rat.
    Mokler DJ; Robinson SE; Johnson JH; Hong JS; Rosecrans JA
    Neurotoxicol Teratol; 1987; 9(4):321-7. PubMed ID: 2446111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat.
    Malone DT; Taylor DA
    Br J Pharmacol; 1998 Aug; 124(7):1419-24. PubMed ID: 9723953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.